The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global tissue banking market reached a value of US$ 1.46 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.83 Billion by 2027, exhibiting at a CAGR of 11.9% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Tissue banking refers to the process of collecting, preparing, and preserving transplantable human tissues for potential therapeutic uses. The tissues obtained are utilized in healing and replacing the affected or lost tissues of the patients. They are also used to repair damaged heart muscles, treat spinal cord injuries, and heal skin from severe burns. At present, advancements in clinical trials and biomedical research are contributing to the demand for tissue preservation and banking across the globe.
The coronavirus disease (COVID-19) pandemic has caused several deaths globally. As a result, researchers are relying on tissue banks to collect tissue specimens, understand cellular responses and the biological impact of infection and identify new therapeutic interventions and prevention strategies. Apart from this, the growing diagnosis of new diseases is escalating the demand for tissue banking in drug discovery. Moreover, the increasing prevalence of chronic diseases is positively influencing the adoption of tissue banks for the transplantation of bones, tendons, corneas, heart valves, and skin. Additionally, the rising geriatric population, in confluence with the growing number of individuals undergoing surgical interventions, is increasing the use of human tissue allografts across the globe. These tissues are used to repair limbs, relieve pain, and improve patients' life quality. Furthermore, the emerging trend of cosmetic surgeries on account of inflating disposable income and the growing consciousness among individuals about physical appearances is driving the market. Besides this, tissue banks can reduce the risk of bacterial and fungal contamination of tissues by using aseptic surgical techniques, equipment and supplies while processing and storing the tissue from the donor. This, in confluence with rising concerns about cross-infection, is creating a positive market outlook.
IMARC Group provides an analysis of the key trends in each sub-segment of the global tissue banking market report, along with forecasts for growth at the global and regional level from 2022-2027. Our report has categorized the market based on product, application and tissue type.
Breakup by Product:
Breakup by Application:
Breakup by Tissue Type:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AMS Biotechnology, Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., Brooks Life Sciences Inc. (Brooks Automation Inc.), Eppendorf AG, Merck KGaA, PHC Corporation, QIAGEN N.V., Sartorius AG, Taylor-Wharton, Thermo Fisher Scientific Inc., and VWR International LLC (Avantor Inc).
|Base Year of the Analysis||2021|
|Segment Coverage||Product, Application, Tissue Type, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||AMS Biotechnology, Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., Brooks Life Sciences Inc. (Brooks Automation Inc.), Eppendorf AG, Merck KGaA, PHC Corporation, QIAGEN N.V., Sartorius AG, Taylor-Wharton, Thermo Fisher Scientific Inc., and VWR International LLC (Avantor Inc)|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
The global tissue banking market was valued at US$ 1.46 Billion in 2021.
We expect the global tissue banking market to exhibit a CAGR of 11.9% during 2022-2027.
The high prevalence of several chronic diseases, along with the increasing adoption of tissue banks
for the transplantation of bones, tendons, corneas, etc., is primarily driving the global tissue banking
The sudden outbreak of the COVID-19 pandemic has led to the rising utilization of tissue banking to
collect tissue specimens and study the biological impact of the SARS-CoV-2 virus, to identify new
therapeutic interventions and prevention strategies.
Based on the product, the global tissue banking market can be categorized into equipment and
media and consumables, where equipment exhibits clear dominance in the market.
Based on the application, the global tissue banking market has been segmented into therapeutics,
medical research, and others. Currently, therapeutics represent the largest market share.
Based on the tissue type, the global tissue banking market can be bifurcated into cardiovascular
tissue, lung tissue, kidney tissue, pancreas tissue, liver tissue, eye tissue, and others. Among these,
cardiovascular tissue currently accounts for the majority of the total market share.
On a regional level, the market has been classified into North America, Europe, Asia-Pacific, Middle
East and Africa, and Latin America, where North America currently dominates the global market.
Some of the major players in the global tissue banking market include AMS Biotechnology, Beckman
Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., Brooks Life Sciences Inc. (Brooks
Automation Inc.), Eppendorf AG, Merck KGaA, PHC Corporation, QIAGEN N.V., Sartorius AG, Taylor-
Wharton, Thermo Fisher Scientific Inc., and VWR International LLC (Avantor Inc).
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at